
Sign up to save your podcasts
Or


While the National Pharmaceutical Pricing Authority (NPPA) recent trade margin rationalisation has reduced the prices of several anti-cancer medicines, experts say India needs comprehensive cancer care, stronger price regulation, greater transparency and expanded public healthcare provision to protect patients from catastrophic expenditure.
Are lower MRPs on cancer drugs translating into affordable care? Here, we discuss.
Guests: Dr. Indu Bhushan, bureaucrat, economist and the first CEO of Ayushman Bharat; Mr. K.M. Gopakumar, legal advisor, senior researcher and public health expert.
Host: Bindu Shajan Perappadan
Producer: Jude Weston
Learn more about your ad choices. Visit megaphone.fm/adchoices
With Ajit Agarkar departing his role as the chief selector of the Indian men's cricket team, Pragyan Ojha now leads a reconstituted five-member selection committee. With the 2027 ODI World Cup on the horizon, how much power do Indian cricket selectors really have?
In this episode of In Focus, we discuss about Agarkar’s legacy, what to expect from Ojha at the helm, and how selectors build and blood a squad.
We also discuss how much say the captain and the coach have, how the scouting network covers India’s enormous domestic talent pool, and whether selectors should explain their decisions in public.
Host: Reuben Joe Joseph
Guest: Amol Karhadkar, Deputy Editor, Sports
Producer: Jude Weston
Learn more about your ad choices. Visit megaphone.fm/adchoices
(This episode was aired on October 5.)
From November 9, 2026, the National Pharmaceutical Pricing Authority (NPPA) is implementing a 30% cap on trade margins for 137 anti-cancer drugs. We go back to the episode that spoke of the soaring cancer drug prices and how can a pooled procurement and value based pricing improve affordability of cancer care in India.
Every year, we record 15.6 lakh new cancer cases, and 9 lakh deaths due to cancer. More than 90% of India’s working population doesn’t have a stable or formal employment. A majority of them are not adequately covered by health insurance. Taken together, this means high out of pocket expenditure for treatment, which imposes a huge economic burden on the patient’s family.
A recent survey showed that the overall prevalence of Catastrophic Health Expenditure (CHE) was 80.4% due to outpatient treatment. Clearly, the stratospheric costs of medicines, diagnostics and consultation fees are unsustainable for most Indians.
Doesn’t the government have a responsibility here? Why can’t off-patent drugs be made cheaper? Can centralised, pooled procurement, and value-based pricing improve affordability of cancer care in India?
Guest: Dr. Indranil, Professor at the School of Government and Public Policy, OP Jindal Global University.
Host: G Sampath, Social Affairs Editor, The Hindu
Producer and editor: Jude Weston
Learn more about your ad choices. Visit megaphone.fm/adchoices
For most Indians, the bulk of their medical expenses come out of pocket. In such a scenario, rapidly rising healthcare costs are no less dangerous than any deadly disease. One major reason for cost escalation is the entry of private equity into India’s healthcare sector.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Earlier this month, the Supreme Court asked the Central government to issue a clear public protocol to curb malpractice in stem cell therapy for autism spectrum disorder. This follows a judgement given in January this year following a petition that raised concerns about the commercial promotion and administration of stem cell “therapy” for autism. The court examined the scientific and regulatory position and held that, given the evidence available at present, stem cell therapy for ASD could not be offered by medical practitioners as a clinical service outside an approved and monitored clinical trial or research setting. The Health Ministry’s current approved list covers 18 adult and 14 paediatric indications. Autism is not on this list.
What are the implications of the Supreme Court order, and why was it necessary? Is stem cell therapy something that is being researched for autism abroad and in India and should this continue? Why is the prevalence of autism believed to be increasing and what should we know about it?
Guest: Dr. Ennapadam S. Krishnamoorthy, neuropsychiatrist and founder, Buddhi Clinic, Chennai
Host: Zubeda Hamid
Producer: Jude Francis Weston
Learn more about your ad choices. Visit megaphone.fm/adchoices
Europe is seeing a wave of protests against economic inequalities and poor living standards. The immediate causes vary across countries, from the housing crisis in Spain and issues with the education system in France to public anger over perceived corruption in Serbia and Albania. But one thing is common: youth at the vanguard. Europe always had space for democratic dissent and has seen major protests to influence state systems and public policy.
But with more and more youth taking the streets across the continent and beyond, are these protests merely reactionary, or is there a generational, existential anxiety at play? Are youth worried they will be worse off than their parents? Here, we discuss.
Guests: Gilles Verniers and Rohit Azad
Host: Vighnesh P. Venkitesh
Learn more about your ad choices. Visit megaphone.fm/adchoices
In May, Pope Leo XIV published his first encyclical, titled Magnifica Humanitas (Magnificent Humanity), on safeguarding human dignity in the age of AI. He later shared on social media that he believes human-created art cannot be replaced by machine-generated art.
Learn more about your ad choices. Visit megaphone.fm/adchoices
The Supreme Court, in a judgement on October 15th, declared that a Hindu who converts to a “non-Hindu” social order cannot claim the benefits of reservation. It reasoned that backwardness can’t be transferred automatically from the Hindu social order to a non-Hindu one after conversion. The judgement came in a case where a Hindu OBC man who had converted to Islam wanted to avail reservation benefits as a Muslim OBC.
Learn more about your ad choices. Visit megaphone.fm/adchoices
The death by suicide of Sahil Wakode, a second year B.Tech student at IIT, Bombay, has sparked protests, allegations of caste discrimination, and demands for institutional reforms.
Learn more about your ad choices. Visit megaphone.fm/adchoices
As José Mourinho's Real Madrid returns to the Camp Nou to face Hansi Flick’s Barcelona, we look at the history, identity and drama behind the Clásico
Learn more about your ad choices. Visit megaphone.fm/adchoices
From the publisher's feed

158 Listeners

11 Listeners

56 Listeners

51 Listeners

88 Listeners

105 Listeners

39 Listeners

22 Listeners

12 Listeners

2 Listeners

15 Listeners

9 Listeners

10 Listeners

94 Listeners

12 Listeners